Market Cap

Pharma Mar, SA Market Capitalization:

€582.6 Million

EUR as of July 1, 2024

US$625.8 Million

business Pharma Mar, SA Company Profile

Pharma Mar, SA Main Stock Listing

BME: PHM

Market Capitalization History of Pharma Mar, SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Pharma Mar, SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €738.2 M -35.44%
Jan. 1, 2023 €1.14 B 13.10%
Jan. 1, 2022 €1.01 B -46.91%
Jan. 1, 2021 €1.90 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Pharma Mar, SA Categories

Spain languages Healthcare languages Biotechnology
Spain Healthcare Spain Biotechnology

Stocks & Indices

Pharma Mar, SA has the following listings and related stock indices.


Stock: BME: PHM

Stock: FSX: PMRA

Stock: OTC: PHMMF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.